Recent director dealings and insider transactions at Boston Scientific Corporation (BSX),
from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
Date
Insider
Type
Shares
2026-07-01
Monson Jonathan
SELL
2,087
2026-07-01
Monson Jonathan
SELL
1,010
2026-07-01
Monson Jonathan
BUY
2,087
2026-05-28
Mahoney Michael F
SELL
386,755
2026-05-20
Pegus Cheryl
BUY
1,770
2026-05-20
Habiger David C
BUY
2,250
2026-05-20
Ludwig Edward J
BUY
3,580
2026-05-19
Habiger David C
BUY
2,200
2026-05-07
Morano Susan E
BUY
1,281
2026-05-07
Morano Susan E
BUY
3,800
Valuation
P/E RatioN/A
Market CapN/A
Beta0.577
Dividend/yrNone
52W High$109.50
52W Low$42.20
52-Week Range
$42.20Now$109.50
2% through annual range
From 52W High−60%
From 52W Low+3.7%
📖 Plain English Summary
Boston Scientific Corporation is at 2% of its 52-week range. Beta 0.577 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for BSX🟢 Bullish⬜ Neutral🔴 Bearish
🤖
DipBuster AI Analysis — BSX
Heuristic · balance sheet, insider filings, price data, academic research
Boston Scientific Corporation — DipBuster Score 51/100
Graham value assessment, NCAV analysis, price zones...
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interv…
